Neuberger Berman Group
SCMP

Neuberger Berman Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Neuberger Berman Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-24,482
Closed -$486K – 1610
2015
Q3 		$486K Buy
+24,482
New +$561K ﹤0.01% 1282

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Neuberger Berman Group's SCMP Position: Q4 2015 in Review

Neuberger Berman Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2015, closing a stake of 24,482 shares — an estimated $486K sold.

Neuberger Berman Group first reported a position in SCMP in Q3 2015 and held it in 1 quarter. The position peaked at $486K in Q3 2015. 149 funds tracked by Wall St. Rank hold SCMP as of Q4 2015.

  • Neuberger Berman Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Neuberger Berman Group sold 24,482 Sucampo Pharmaceuticals, Inc. shares in Q4 2015, an estimated $486K.
  • Neuberger Berman Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Neuberger Berman Group's Sucampo Pharmaceuticals, Inc. position peaked at $486K in Q3 2015.
  • 149 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2015.

Based on Neuberger Berman Group's 13F filing for Q4 2015, filed 28 Jan 2016.